106 related articles for article (PubMed ID: 1324685)
1. Phospholipase A2 inhibition by alkylbenzoylacrylic acids.
Köhler T; Heinisch M; Kirchner M; Peinhardt G; Hirschelmann R; Nuhn P
Biochem Pharmacol; 1992 Aug; 44(4):805-13. PubMed ID: 1324685
[TBL] [Abstract][Full Text] [Related]
2. Effects of pancreatic and snake venom phospholipase A2 on the generation of leukotriene B4 and C4 by human leukocytes in vitro.
Shimizu T; Hansson GC; Strandvik B
Pancreas; 1994 Jan; 9(1):37-41. PubMed ID: 8108369
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase A2 as leukotriene B4 secretagogue for human polymorphonuclear leukocytes.
Lam BK; Yang CY; Wong PY
Adv Exp Med Biol; 1990; 275():183-91. PubMed ID: 2173367
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 (PLA2) releases lipoxins and leukotrienes from endogenous sources.
Lam BK; Lee CY; Wong PY
Ann N Y Acad Sci; 1988; 524():27-34. PubMed ID: 2837961
[No Abstract] [Full Text] [Related]
5. Inactivation of phospholipase A2 by manoalide. Localization of the manoalide binding site on bee venom phospholipase A2.
Glaser KB; Vedvick TS; Jacobs RS
Biochem Pharmacol; 1988 Oct; 37(19):3639-46. PubMed ID: 3178877
[TBL] [Abstract][Full Text] [Related]
6. The effects of two phospholipase A2 inhibitors on the neuromuscular blocking activities of homologous phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake.
Fatehi M; Rowan EG; Harvey AL
Toxicon; 1995 Dec; 33(12):1633-43. PubMed ID: 8866620
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of manoalide on secreted and intracellular phospholipases.
Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST
Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628
[TBL] [Abstract][Full Text] [Related]
8. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses.
Kohler C; Carroll M; Tarrant E; Torley L; Wissner A
Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926
[TBL] [Abstract][Full Text] [Related]
9. Induction of endogenous arachidonic acid metabolism in human neutrophils with snake venom phospholipase A2, immune complexes, and A23187.
Langholz E; Nielsen OH
Prostaglandins Leukot Essent Fatty Acids; 1990 Mar; 39(3):227-9. PubMed ID: 2159646
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A2 inhibition by alkylbenzoylacrylic acids.
Köhler T; Friedrich G; Nuhn P
Agents Actions; 1991 Jan; 32(1-2):70-2. PubMed ID: 2058477
[No Abstract] [Full Text] [Related]
12. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet and neutrophil phospholipase A2 by hydroxyeicosatetraenoic acids (HETES). A novel pharmacological mechanism for regulating free fatty acid release.
Chang J; Blazek E; Kreft AF; Lewis AJ
Biochem Pharmacol; 1985 May; 34(9):1571-5. PubMed ID: 3994765
[TBL] [Abstract][Full Text] [Related]
14. Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.
Glaser KB; Jacobs RS
Biochem Pharmacol; 1986 Feb; 35(3):449-53. PubMed ID: 3947381
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.
Reynolds LJ; Mihelich ED; Dennis EA
J Biol Chem; 1991 Sep; 266(25):16512-7. PubMed ID: 1885583
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
[TBL] [Abstract][Full Text] [Related]
17. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.
Burke JR; Davern LB; Stanley PL; Gregor KR; Banville J; Remillard R; Russell JW; Brassil PJ; Witmer MR; Johnson G; Tredup JA; Tramposch KM
J Pharmacol Exp Ther; 2001 Jul; 298(1):376-85. PubMed ID: 11408565
[TBL] [Abstract][Full Text] [Related]
18. Oligomers of prostaglandin B1 inhibit arachidonic acid mobilization in human neutrophils and endothelial cells.
Rosenthal MD; Franson RC
Biochim Biophys Acta; 1989 Dec; 1006(3):278-86. PubMed ID: 2557075
[TBL] [Abstract][Full Text] [Related]
19. The edema inducing activity of phospholipase A2 enzymes.
Tan NH; Saifuddin MN; Yong WY
Biochem Int; 1991 Jan; 23(1):175-81. PubMed ID: 1863271
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide.
Jacobson PB; Marshall LA; Sung A; Jacobs RS
Biochem Pharmacol; 1990 May; 39(10):1557-64. PubMed ID: 2337412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
